Stockreport

Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray [Yahoo! Finance]

AptarGroup, Inc.  (ATR) 
Last aptargroup, inc. earnings: 4/30 05:04 pm Check Earnings Report
US:NYSE Investor Relations: investors.aptar.com
PDF Aptar's Intranasal Delivery System Utilized in Phase II Clinical Study of SPONTAN® Nasal Spray Supporting advancement of complex intranasal therapies through clinical [Read more]